1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARS PHARMACEUTICALS INC
ARS Pharmaceuticals Inc
XNAS: SPRY
4.08 -0.07 (-1.69%)
1.0M
XNAS Volume

XNAS 25 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

ARS Pharma Inc - SPRY - stock price prediction, stock price target, analyst ratings from 4 analysts

ARS Pharma Inc has a share price target of US$ 22, revenue growth forecast of 54.1%, and profit growth estimate of -7.4% for FY26, based on top 4 analyst calls.